Atlant Clinical’s management team has been constructed from high-ranking offices at some of the world’s leading pharmaceutical and biotechnical companies.

Mikhail Groubman



Michael joined Atlant Clinical as Chief Executive Officer in 2012. He has led the company from local niche CRO to become one of the principal international providers of clinical studies and support services within the healthcare industry. Prior to Atlant Clinical, Michael was at GlaxoSmithKline, where he worked in a variety of leadership positions within Sales and Market Access groups.

Polina Kim



Polly joined Atlant Clinical in 2012 as Project Manager and quickly moved on to QA Manager and then QA and Training Director. She has played a key role in the development of high quality standards, helping to earn Atlant an ISO 9001: 2008 quality in Organization and Management of Clinical Trials. Polly began her career in clinical trials at GlaxoSmithKline. Before Atlant, she was Global Lead CRA in international trials at Novartis.

Elena Dementyeva


Dr. Dementyeva has been with Atlant Clinical since its inception and has been instrumental in the company’s growth. Elena has led hundreds of trials across all major therapeutic areas. As Project Management Director, Elena coordinates the efforts all Atlant project managers, ensuring successful clinical operations in each of our geographic locations across the globe. Dr. Dementyeva began her career in clinical studies at GlaxoWellcome, before moving on to work as Project Manager for US contract research organization, ClinStar.

Timur Zagidullin



Timur joined Atlant Clinical in 2015 as a Biostatistician. He was responsible for execution of statistical support of clinical studies from design to reporting utilizing SAS-programming and international standards of data CDISC.

Timur started his career in clinical research as a CRA in Janssen, and later worked at Medical Department at AbbVie.